Junctional Adhesion Molecules (JAM)-B and -C Contribute to Leukocyte Extravasation to the Skin and Mediate Cutaneous Inflammation
- 1 November 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 125 (5) , 969-976
- https://doi.org/10.1111/j.0022-202x.2005.23912.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lymphocyte trafficking to inflamed skin – molecular mechanisms and implications for therapeutic target moleculesEmerging Therapeutic Targets, 2005
- JAM-C Is a Component of Desmosomes and a Ligand for CD11b/CD18-mediated Neutrophil Transepithelial MigrationMolecular Biology of the Cell, 2004
- The Molecular Basis of Lymphocyte Recruitment to the Skin: Clues for Pathogenesis and Selective Therapies of Inflammatory DisordersJournal of Investigative Dermatology, 2003
- Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migrationBlood, 2002
- The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1The Journal of Experimental Medicine, 2002
- JAM2 Interacts with α4β1Journal of Biological Chemistry, 2002
- Junctional Adhesion Molecule (JAM) Is Phosphorylated by Protein Kinase C upon Platelet ActivationBiochemical and Biophysical Research Communications, 2000
- T-Cell Function and Migration — Two Sides of the Same CoinNew England Journal of Medicine, 2000
- Antibodies to the Junctional Adhesion Molecule Cause Disruption of Endothelial Cells and Do Not Prevent Leukocyte Influx into the Meninges after Viral or Bacterial InfectionThe Journal of Infectious Diseases, 2000
- Lymphocyte Homing and HomeostasisScience, 1996